Results 81 to 90 of about 30,963 (261)

Implantable drug delivery system: Frontiers of medicine‐engineering interdisciplinary

open access: yesInterdisciplinary Medicine, EarlyView.
This review systematically summarizes the driving mechanisms of implantable on‐demand drug delivery systems (IDDS), including endogenous, exogenous, and closed‐loop strategies. It highlights the pivotal roles of flexible electronics and miniaturization in enhancing the tissue conformity and spatial adaptability.
Yu Zeng   +9 more
wiley   +1 more source

Microperimetry – A New Tool for Assessing Retinal Sensitivity in Macular Diseases [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Macular disease is the leading cause of low vision in the Western world. Drusen and pigmentary irregularities are common among the rural Northern Indian population.
Memota Laishram   +4 more
doaj   +1 more source

Associations Between Initial Glycated Hemoglobin at Diabetes Diagnosis, Longitudinal Changes and Medication Effects, and the Severity and Progression of Sight‐Threatening Diabetic Retinopathy

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic retinopathy (DR) is a leading cause of vision impairment in patients diagnosed with Type 2 diabetes mellitus (T2DM). Awareness of risk factors is necessary to reduce or prevent harmful effects of DR such as irreversible vision loss, and to help ensure early treatment.
Yu‐Chi Sung   +8 more
wiley   +1 more source

DIAbetic macular oedema aNd diode subthreshold micropulse laser (DIAMONDS) : Ppotocol for a randomised clinical trial [PDF]

open access: yes, 2019
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Acharya, Nachiketa   +27 more
core   +1 more source

Anti-VEGF Therapy and the Retina: An Update

open access: yesJournal of Ophthalmology, 2015
Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring ...
Vikas Tah   +7 more
doaj   +1 more source

Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema [PDF]

open access: yes, 2014
Diabetic macular oedema (DMO) is a leading cause of vision loss in the working-age population worldwide. Corticosteroid drugs have been demonstrated to inhibit the expression of both the vascular endothelial growth factor (VEGF) gene and other anti ...
Alkabes, M, Dutra-Medeiros, M, Nucci, P
core   +1 more source

A reference standard for the measurement of macular oedema [PDF]

open access: yesBritish Journal of Ophthalmology, 2006
Macular oedema is associated with several conditions that lead to blindness. Accurate measurement of macular thickness is important in order to follow disease progression and evaluate treatments. Four techniques are examined to determine the best reference standard for the detection and quantification of macular oedema: ultrasound, optical coherence ...
openaire   +2 more sources

Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence Tomography

open access: yesThe Laryngoscope, EarlyView.
The purpose of this study is to use optical coherence tomography (OCT) to characterize the effect of dehydration on the optical attenuation coefficient of porcine vocal fold (VF) tissue. The optical attenuation coefficient tissue decreased linearly with dehydration, dropping by approximately 0.08 mm−1 for every 1% increase in mass loss.
Owen P. Wischhoff   +4 more
wiley   +1 more source

Retinopathy in old persons with and without diabetes mellitus: the Age, Gene/Environment Susceptibility--Reykjavik Study (AGES-R). [PDF]

open access: yes, 2012
To access full text version of this article. Please click on the hyperlink "View/open" at the bottom of this pageWe aimed to describe the prevalence of retinopathy in an aged cohort of Icelanders with and without diabetes mellitus.
Aspelund, T   +11 more
core   +1 more source

Diabetic retinopathy in Greenland and Denmark—Can differences in risk factors explain the lower prevalence in Greenland?

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The prevalence of diabetic retinopathy (DR) is low in Greenland. Factors underlying the low prevalence may potentially protect against the development of DR. Comparing Greenlandic and Danish populations, this register‐based study explored differences in risk factors that may explain differences in DR prevalence.
Jonas Bjørn Skjøth   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy